pemafibrate
Kowa Pharmaceuticals
[]
honored to discuss the #prominent trial at #aha22. we need to prioritize medications with demonstrated risk reduction and re-think those without 
Passionate about #Cardiology, #WIC, and #healthequity. PD @UCLACVfellows